OBJECTIVE: This pilot study tested the efficacy of a brief, novel, theory-driven, self-guided, home-based intervention designed to promote condom use among young men who have sex with men (YMSM). PARTICIPANTS: Thirty YMSM were recruited from a large public US midwestern university during spring of 2012. METHODS: The intervention was tested using a repeated measures design with the primary follow-up assessment occurring 6 weeks after enrollment. RESULTS: Forty-five percent of men reported a reduced frequency of unprotected insertive penile-anal intercourse in the past 30 days compared with baseline (p = .01). Consistency of condom use improved (p = .013), as did motivation to use condoms correctly, condom use self-efficacy, and condom attitudes. All participants indicated that they were glad they participated, would recommend the program, and that overall, they had liked the program. CONCLUSIONS: This pilot study supports an expanded trial of this intervention with MSM at high-risk of acquiring human immunodeficiency virus/sexually transmitted infections (HIV/STIs).
OBJECTIVE: This pilot study tested the efficacy of a brief, novel, theory-driven, self-guided, home-based intervention designed to promote condom use among young men who have sex with men (YMSM). PARTICIPANTS: Thirty YMSM were recruited from a large public US midwestern university during spring of 2012. METHODS: The intervention was tested using a repeated measures design with the primary follow-up assessment occurring 6 weeks after enrollment. RESULTS: Forty-five percent of men reported a reduced frequency of unprotected insertive penile-anal intercourse in the past 30 days compared with baseline (p = .01). Consistency of condom use improved (p = .013), as did motivation to use condoms correctly, condom use self-efficacy, and condom attitudes. All participants indicated that they were glad they participated, would recommend the program, and that overall, they had liked the program. CONCLUSIONS: This pilot study supports an expanded trial of this intervention with MSM at high-risk of acquiring human immunodeficiency virus/sexually transmitted infections (HIV/STIs).
Authors: Stephanie A Sanders; Brandon J Hill; Erick Janssen; Cynthia A Graham; Richard A Crosby; Robin R Milhausen; William L Yarber Journal: J Sex Med Date: 2015-08-17 Impact factor: 3.802
Authors: Nathan John Lachowsky; Zach Tanner; Zishan Cui; Paul Sereda; Asheligh Rich; Jody Jollimore; Julio Sg Montaner; Robert S Hogg; David M Moore; Eric A Roth Journal: Sex Transm Dis Date: 2016-12 Impact factor: 2.830
Authors: N J Lachowsky; C E Dewey; N P Dickson; P J W Saxton; A J Hughes; R R Milhausen; A J S Summerlee Journal: Sex Transm Infect Date: 2015-01-20 Impact factor: 3.519
Authors: Matthew M Hamill; Fengming Hu; Afoke Kokogho; Elizabeth Shoyemi; Charles Ekeh; Manhattan E Charurat; Merlin L Robb; Sylvia Adebajo; Stefan D Baral; Rebecca G Nowak; Trevor A Crowell Journal: J Acquir Immune Defic Syndr Date: 2021-03-01 Impact factor: 3.771